Patent · US Active

Methods and materials for treating cancer

US12264189B2 · kind B2 · utility

0Cited by
125References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2019
Grant dateApr 1, 2025
Priority date
Expiry dateMay 1, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This document provides methods and materials for generating T cells expressing a selected antigen receptor (e.g., a chimeric antigen receptor) in vivo. For example, viral particles containing nucleic acid encoding a selected antigen receptor, cells capable of producing such viral particles, and methods for administering such viral particles and/or cells to a mammal to generate T cells expressing that selected antigen receptor within the mammal are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.